Ideal for individuals experiencing visible thinning, the 1% AHK-Cu Treatment Spray is designed for consistent daily use to maintain optimal scalp condition and long-term hair vitality
Musculoskeletal Healing Protocols: Investigating the acceleration of cellular repair mechanisms in injured tendons, ligaments, skeletal muscle, and bone interfaces
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, not yet approved by the MHRA or EMA for use in the UK
Botox is designated as a US Food and Drug Administration (FDA) pregnancy category C medicine, meaning that there are no well controlled studies in pregnant women, so it should only be used during pregnancy if the benefits outweigh the potential risks, which is typically the sentiment nowadays
Statements made on this website have not been evaluated by the Food and Drug Administration